Teva reflects robust future for generic drug makers

11/5/2007 | CNNMoney

The growing demand for more affordable drugs around the world is key to Teva Pharmaceutical Industries Ltd.'s promising performance in the coming years, according to analysts. Teva, the world's largest generic drug maker, aggressively pursues legal challenges to patent-protected drugs in order to get its own versions into the market, and consequently it has more than 150 abbreviated new drug applications pending with the FDA.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park